Leaflet MOVALIS 7.5mg tablets

Product code: W04104001 Quantity: 20

Indicated for: pain and inflammation

Route of administration: oral

Substance: meloxicam (nonsteroidal anti-inflammatory drug)

ATC: M01AC06 (Musculo-skeletal system | Antiinflammatory and antirheumatic products, non-steroids | Oxicams)

Precautions:
Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Nephrotoxicity
Nephrotoxicity

This medicine may affect the kidneys.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Bleeding risk
Bleeding risk

This medicine may increase the risk of bleeding.

Ulcer / gastrointestinal bleeding
Ulcer / gastrointestinal bleeding

This medicine may increase the risk of ulcer or gastrointestinal bleeding.

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It works by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), reducing the production of prostaglandins, substances involved in inflammation, pain, and fever.

Meloxicam is available in tablet, capsule, or injectable forms and is preferred for long-term use due to its lower risk of gastrointestinal side effects compared to other NSAIDs.

Side effects may include nausea, stomach pain, dizziness, diarrhea, or constipation. In rare cases, it can cause gastric ulcers, gastrointestinal bleeding, or allergic reactions. Long-term use may increase the risk of cardiovascular events. It is important to take the medication as prescribed by a doctor.

General data about MOVALIS 7.5mg

  • Substance: meloxicam
  • Date of latest medicines list: 01-06-2026
  • Product code: W04104001
  • Concentration: 7.5mg
  • Pharmaceutical form: tablets
  • Quantity: 20
  • Product type: Original
  • Price: 14.24 RON
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

  • Manufacturer: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG - GERMANIA
  • Holder: BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA
  • Number: 7195/2014/02
  • Shelf life: 3 years

Pharmaceutical forms available for meloxicam

Concentrations available for meloxicam

  • 15mg
  • 15mg/1.5ml
  • 15mg/ml
  • 7.5mg

Other substances similar to meloxicam

Compensation lists for MOVALIS 7.5mg Boehringer

A - Sublist A with 90% discount from the reference price

Price

Copayment

Patient

14.24 RON

6.14 RON

8.10 RON